LFMD on Nasdaq

LifeMD, Inc.

LifeMD brand is our flagship virtual primary care and specialty platform, having served over 679,000 customers and patients to date.3 From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with SBC Medical Group Holdings Inc, Airsculpt Technologies, Inc. or Starling Oncology, Inc., or pick any stock.

  • TickerLFMD on Nasdaq1
  • IndustryServices-Offices & Clinics of Doctors of Medicine1
  • HeadquartersNew York, New York1
  • Incorporated inDE2
  • Business address236 Fifth Avenue, Suite 400, New York, Ny 100012
  • Filer categoryAccelerated filer2

See how the biggest companies compare on our leaderboards

LifeMD brand is our flagship virtual primary care and specialty platform, having served over 679,000 customers and patients to date.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

85.7%Gross margin4
-4.0%Operating margin4
7.4%Net margin4
25.3%Revenue growth, 20254
62.0%Return on equity4
$6.4MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Telehealth Subscription Revenue brought in 58% of the revenue LifeMD, Inc. broke down this way in fiscal 2025.

  1. Telehealth Subscription Revenue$113.3M458%up 67% from 2024
  2. Telehealth$80.8M442%down 2% from 2024
Business segments by year
Business segments20242025
Telehealth Subscription Revenue$67.7M$113.3M
Telehealth$82.1M$80.8M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue14¢$27.7M
  • Other costs78¢$150.6M
  • Interest1¢$1.4M
  • Income tax0¢$45.7K
  • Profit7¢$14.4M

Out of $194.1M in revenue.4

Where each dollar of operating cash went, fiscal 2025

  • Capital spending23¢$1.9M
  • Dividends paid38¢$3.1M
  • Share buybacks3¢$270.0K
  • Kept or used elsewhere37¢$3.0M

Out of $8.3M of cash from operations.4

Financial statements

Revenue567894$194.1M in 2025+1456% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $12.5M$12.5M20192020: $37.3M$37.3M2020+199%2021: $92.9M$92.9M2021+149%2022: $119.0M$119.0M2022+28%2023: $152.5M$152.5M2023+28%2024: $154.8M$154.8M2024+1%2025: $194.1M$194.1M2025+25%
Gross profit567894$166.3M in 2025+1573% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $9.9M$9.9M20192020: $28.4M$28.4M2020+186%2021: $74.9M$74.9M2021+163%2022: $100.4M$100.4M2022+34%2023: $133.6M$133.6M2023+33%2024: $133.4M$133.4M2024−0%2025: $166.3M$166.3M2025+25%
Operating income567894-$7.7M in 2025+165% since 2019
-$60.0M-$40.0M-$20.0M02019: -$2.9M-$2.9M20192020: -$57.8M-$57.8M2020+1901%2021: -$54.3M-$54.3M2021−6%2022: -$43.4M-$43.4M2022−20%2023: -$14.5M-$14.5M2023−67%2024: -$20.4M-$20.4M2024+41%2025: -$7.7M-$7.7M2025−62%
Net income567894$14.4M in 2025
-$80.0M-$60.0M-$40.0M-$20.0M0$20.0M2019: -$3.1M-$3.1M20192020: -$58.6M-$58.6M2020+1769%2021: -$60.9M-$60.9M2021+4%2022: -$45.5M-$45.5M2022−25%2023: -$20.6M-$20.6M2023−55%2024: -$21.4M-$21.4M2024+4%2025: $14.4M$14.4M2025
Fiscal year2019202020212022202320242025
Revenue$12.5M5$37.3M6$92.9M7$119.0M8$152.5M9$154.8M4$194.1M4
Cost of revenue$2.5M5$8.9M6$18.0M7$18.7M8$18.9M9$21.4M4$27.7M4
Gross profit$9.9M5$28.4M6$74.9M7$100.4M8$133.6M9$133.4M4$166.3M4
Research and development
Operating expenses$129.2M7$143.8M8$148.1M9$153.8M4$174.0M4
Operating income-$2.9M5-$57.8M6-$54.3M7-$43.4M8-$14.5M9-$20.4M4-$7.7M4
Interest$761.1K5$1.7M6$3.0M7$1.3M8$2.6M9$2.2M4$1.4M4
Income before tax-$61.3M7-$44.7M8-$17.4M9-$22.6M4-$10.2M4
Income tax-$122.5K5$122.5K6$7.7K7$360.7K8$428.0K9$598.0K4$45.7K4
Net income-$3.1M5-$58.6M6-$60.9M7-$45.5M8-$20.6M9-$21.4M4$14.4M4
Earnings per share-$0.604$0.254
Earnings per share (diluted)-$0.604$0.254
Shares (weighted, basic)27.0M shares731.0M shares833.9M shares941.2M shares445.1M shares4
Shares (weighted, diluted)27.0M shares731.0M shares833.9M shares941.2M shares445.1M shares4

Compare LifeMD, Inc. with another company

Leadership

Who has led LifeMD, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Justin Schreiber2018–now

Chair

  1. Justin Schreiber2025–now

President

  1. Justin Schreiber2017–2018
  2. Alexander Mironov2021–2023

Chief financial officer

  1. Robert L. Kalkstein2017–2019
  2. Dagnery Juan Manuel Pineiro2019
  3. Marc David Benathen2021–2026
  4. Atul Kavthekar2026–now

Chief operating officer

  1. Stefan Galluppi2017–2020
  2. Brad Michael Roberts2021–2023
  3. Shayna Webb Dray2025–now
20202025
Board members and other officers (30)

Former names

  • CONVERSION LABS, INC.Jun 27, 2018 to Feb 22, 20212
  • Immudyne, Inc.May 17, 2012 to Jun 19, 20182

Timeline

  1. Mar 28, 2018New chief executive Justin Schreiber becomes CEO12

Filings

261 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 48 major events, 129 insider forms, 5 large holders, 59 other. The latest 20:

  1. Sep 25, 2026S-8 EDGAR
  2. Sep 15, 20268-K EDGAR
  3. Aug 18, 20264 EDGAR
  4. Aug 18, 20264 EDGAR
  5. Aug 13, 20264 EDGAR
  6. Aug 13, 20264/A EDGAR
  7. Aug 13, 20264 EDGAR
  8. Aug 13, 20264 EDGAR
  9. Aug 5, 202610-Q EDGAR
  10. Aug 5, 20268-K EDGAR
  11. Jun 22, 20268-K EDGAR
  12. Jun 3, 20264 EDGAR
  13. Jun 3, 20263 EDGAR
  14. May 13, 20264 EDGAR
  15. May 6, 202610-Q EDGAR
  16. May 6, 20268-K EDGAR
  17. Apr 30, 2026ARS EDGAR
  18. Apr 30, 2026DEFA14A EDGAR
  19. Apr 30, 2026DEFA14A EDGAR
  20. Apr 30, 2026DEF 14A EDGAR

The 261 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

46 open-market trades by officers, directors and large owners since October 2021: 30 buys and 16 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 9, 2025FRIEDEMAN JESSICAChief Marketing OfficerSale15,000$3.61$54.1KForm 4
Sep 10, 2025Alvarez Nicholas PChief Acquisition OfficerSale75,000$5.92$444.0KForm 4
Jul 1, 2025Schreiber JustinChairman and CEOSale25,000$9.99$249.8KForm 4
Jul 1, 2025Schreiber JustinChairman and CEOSale25,000$13.38$334.5KForm 4
Jun 17, 2025Benathen Marc DavidChief Financial OfficerSale50,000$14.01$700.5KForm 4
Jun 16, 2025Benathen Marc DavidChief Financial OfficerSale75,000$13.09$981.8KForm 4
Jun 13, 2025Yecies Eric HaroldChief Legal Officer & GCSale15,000$12.25$183.8KForm 4
Jun 13, 2025Galluppi StefanChief Innovation OfficerSale85,000$12.38$1.1MForm 4
Jun 2, 2025Schreiber JustinChairman and CEOSale25,000$12.47$311.8KForm 4
May 2, 2025Schreiber JustinChairman and CEOSale3,005$7.50$22.5KForm 4
May 1, 2025Schreiber JustinChairman and CEOSale21,995$7.53$165.6KForm 4
Apr 29, 2025Schreiber JustinChairman and CEOSale50,000$7.78$389.0KForm 4
Mar 14, 2025FRIEDEMAN JESSICAChief Marketing OfficerSale30,000$5.66$169.8KForm 4
Feb 14, 2025Schreiber JustinChairman and CEOSale50,000$7.55$377.5KForm 4
Jan 2, 2025Schreiber JustinChairman and CEOSale25,000$5.19$129.8KForm 4
Dec 2, 2024Schreiber JustinChairman and CEOSale25,000$6.52$163.0KForm 4
Sep 11, 2024Galluppi StefanChief Innovation OfficerBuy3,000$4.93$14.8KForm 4
Aug 31, 2023Velge BertrandDirectorBuy60,000$3.93$235.8KForm 4
Aug 30, 2023Velge BertrandDirectorBuy40,000$3.76$150.4KForm 4
Aug 29, 2023Velge BertrandDirectorBuy32,072$3.58$114.8KForm 4

All 46 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.3,034,535$12.5M0.0%+225,510
Federated Hermes, Inc.2,747,655$11.3M0.0%+1,728,578
Vanguard Capital Management LLC1,734,756$7.2M0.0%+71,060
State Street Corp1,318,784$5.4M0.0%+243,376
Renaissance Technologies LLC1,079,525$4.5M0.0%−38,800
Geode Capital Management, LLC1,067,698$4.4M0.0%+48,257
Prescott Group Capital Management, L.L.C.897,224$3.7M0.3%+1,800
BRC Group Holdings, Inc.637,319$2.6M0.6%−234,261
Royce & Associates LP636,124$2.6M0.0%−565,527
Aqr Capital Management LLC619,506$2.6M0.0%+421,184
Marshall Wace, Llp557,474$2.3M0.0%+300,339
Susquehanna International Group, Llp478,276$2.0M0.0%+13,083
Morgan Stanley404,121$1.7M0.0%+39,632
Millennium Management LLC401,624$1.7M0.0%New
Northern Trust Corp357,309$1.5M0.0%+22,500
Jacobs Levy Equity Management, Inc335,487$1.4M0.0%New
Walleye Capital LLC323,898$1.3M0.0%New
Russell Investments Group, Ltd.314,770$1.3M0.0%+309,436
Vanguard Fiduciary Trust Co283,953$1.2M0.0%−4,959
Tudor Investment Corp Et Al274,143$1.1M0.0%New
Vanguard Portfolio Management LLC273,004$1.1M0.0%+40,413
Citadel Advisors LLC263,471$1.1M0.0%New
Bank Of America Corp /de/261,014$1.1M0.0%+212,311
Bank of New York Mellon Corp246,586$1.0M0.0%+5,651
Penn Capital Management Company, LLC224,235$926.1K0.1%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52